Iron oxide nanoparticles: A promising approach for diagnosis and treatment of cardiovascular diseases

Daghem, M.; Bing, R.; Fayad, Z. A.; Dweck, M. R. Noninvasive imaging to assess atherosclerotic plaque composition and disease activity: Coronary and carotid applications. JACC Cardiovasc. Imaging 2020, 13, 1055–1068.

Levine, G. N.; Bates, E. R.; Blankenship, J. C.; Bailey, S. R.; Bittl, J. A.; Cercek, B.; Chambers, C. E.; Ellis, S. G.; Guyton, R. A.; Hollenberg, S. M. et al. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: An update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the american college of cardiology/american heart association task force on clinical practice guidelines and the society for cardiovascular angiography and interventions. Circulation 2016, 133, 1135–1147.

Knuuti, J.; Wijns, W.; Saraste, A.; Capodanno, D.; Barbato, E.; Funck-Brentano, C.; Prescott, E.; Storey, R. F.; Deaton, C.; Cuisset, T. et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes: The task force for the diagnosis and management of chronic coronary syndromes of the European society of cardiology (ESC). Eur. Heart J. 2020, 41, 407–477.

Li, Y.; Cao, G. Y.; Jing, W. Z.; Liu, J.; Liu, M. Global trends and regional differences in incidence and mortality of cardiovascular disease, 1990-2019: Findings from 2019 global burden of disease study. Eur. J. Prev. Cardiol. 2023, 30, 276–286.

Marquina, C.; Talic, S.; Vargas-Torres, S.; Petrova, M.; Abushanab, D.; Owen, A.; Lybrand, S.; Thomson, D.; Liew, D.; Zomer, E. et al. Future burden of cardiovascular disease in Australia: Impact on health and economic outcomes between 2020 and 2029. Eur. J. Prev. Cardiol. 2022, 29, 1212–1219.

Hu, Q. Q.; Fang, Z. Y.; Ge, J. B.; Li, H. Nanotechnology for cardiovascular diseases. Innovation 2022, 3, 100214.

Younis, N. K.; Ghoubaira, J. A.; Bassil, E. P.; Tantawi, H. N.; Eid, A. H. Metal-based nanoparticles: Promising tools for the management of cardiovascular diseases. Nanomedicine 2021, 36, 102433.

Alam, S. R.; Stirrat, C.; Richards, J.; Mirsadraee, S.; Semple, S. I. K.; Tse, G.; Henriksen, P.; Newby, D. E. Vascular and plaque imaging with ultrasmall superparamagnetic particles of iron oxide. J. Cardiovasc. Magn. Reson. 2015, 17, 83.

Bietenbeck, M.; Florian, A.; Faber, C.; Sechtem, U.; Yilmaz, A. Remote magnetic targeting of iron oxide nanoparticles for cardiovascular diagnosis and therapeutic drug delivery: Where are we now. Int. J. Nanomedicine 2016, 11, 3191–3203.

Montiel Schneider, M. G.; Lassalle, V. L. Magnetic iron oxide nanoparticles as novel and efficient tools for atherosclerosis diagnosis. Biomed. Pharmacother. 2017, 93, 1098–1115.

Billings, C.; Langley, M.; Warrington, G.; Mashali, F.; Johnson, J. A. Magnetic particle imaging: Current and future applications, magnetic nanoparticle synthesis methods and safety measures. Int. J. Mol. Sci. 2021, 22, 7651.

Renella, P.; Li, J.; Prosper, A. E.; Finn, J. P.; Nguyen, K. L. Ferumoxytol-enhanced cardiac magnetic resonance angiography and 4D flow: Safety and utility in pediatric and adult congenital heart disease. Children 2022, 9, 1810.

Lu, Y.; Huang, J.; Neverova, N. V.; Nguyen, K. L. USPIOs as targeted contrast agents in cardiovascular magnetic resonance imaging. Curr. Cardiovasc. Imaging Rep. 2021, 14, 2.

Arias, L. S.; Pessan, J. P.; Vieira, A. P. M.; de Lima, T. M. T.; Delbem, A. C. B.; Monteiro, D. R. Iron oxide nanoparticles for biomedical applications: A perspective on synthesis, drugs, antimicrobial activity, and toxicity. Antibiotics 2018, 7, 46.

Ali, A.; Zafar, H.; Zia, M.; Ul Haq, I.; Phull, A. R.; Ali, J. S.; Hussain, A. Synthesis, characterization, applications, and challenges of iron oxide nanoparticles. Nanotechnol. Sci. Appl. 2016, 9, 49–67.

Dadfar, S. M.; Roemhild, K.; Drude, N. I.; von Stillfried, S.; Knüchel, R.; Kiessling, F.; Lammers, T. Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications. Adv. Drug Deliv. Rev. 2019, 138, 302–325.

Wu, W.; Wu, Z. H.; Yu, T.; Jiang, C. Z.; Kim, W. S. Recent progress on magnetic iron oxide nanoparticles: Synthesis, surface functional strategies and biomedical applications. Sci. Technol. Adv. Mater. 2015, 16, 023501.

Mao, Y.; Li, Y.; Gu, N. Progress in the preparation of iron based magnetic nanoparticles for biomedical applications. J. Harbin Inst. Technol. (New Ser. ) 2019, 26, 1–18.

Laurent, S.; Forge, D.; Port, M.; Roch, A.; Robic, C.; Vander Elst, L.; Muller, R. N. Magnetic iron oxide nanoparticles: Synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem. Rev. 2008, 108, 2064–2110.

Minamihara, H.; Kusada, K.; Wu, D. S.; Yamamoto, T.; Toriyama, T.; Matsumura, S.; Kumara, L. S. R.; Ohara, K.; Sakata, O.; Kawaguchi, S. et al. Continuous-flow reactor synthesis for homogeneous 1 nm-sized extremely small high-entropy alloy nanoparticles. J. Am. Chem. Soc. 2022, 144, 11525–11529.

Mao, Y.; Li, Y.; Zang, F. C.; Yu, H. L.; Yan, S.; Song, Q. S.; Qin, Z. G.; Sun, J. F.; Chen, B.; Huang, X. et al. Continuous synthesis of extremely small-sized iron oxide nanoparticles used for T₁-weighted magnetic resonance imaging via a fluidic reactor. Sci. China Mater. 2022, 65, 1646–1654.

Mao, Y.; Li, Y.; Guo, Z. H.; Chen, B.; Qin, Z. G.; Zhang, Z. H.; Sun, J. F.; Gu, N. The coprecipitation formation study of iron oxide nanoparticles with the assist of a gas/liquid mixed phase fluidic reactor. Colloids Surf. A Physicochem. Eng. Asp. 2022, 647, 129107.

La Mer, V. K.; Dinegar, R. H. Theory, production and mechanism of formation of monodispersed hydrosols. J. Am. Chem. Soc. 1950, 72, 4847–4854.

Cotin, G.; Kiefer, C.; Perton, F.; Ihiawakrim, D.; Blanco-Andujar, C.; Moldovan, S.; Lefevre, C.; Ersen, O.; Pichon, B.; Mertz, D. et al. Unravelling the thermal decomposition parameters for the synthesis of anisotropic iron oxide nanoparticles. Nanomaterials 2018, 8, 881.

Hatakeyama, M.; Kishi, H.; Kita, Y.; Imai, K.; Nishio, K.; Karasawa, S.; Masaike, Y.; Sakamoto, S.; Sandhu, A.; Tanimoto, A. et al. A two-step ligand exchange reaction generates highly water-dispersed magnetic nanoparticles for biomedical applications. J. Mater. Chem. 2011, 21, 5959–5966.

Cai, W.; Wan, J. Q. Facile synthesis of superparamagnetic magnetite nanoparticles in liquid polyols. J. Colloid Interface Sci. 2007, 305, 366–370.

Hachani, R.; Lowdell, M.; Birchall, M.; Hervault, A.; Mertz, D.; Begin-Colin, S.; Thanh, N. T. Polyol synthesis, functionalisation, and biocompatibility studies of superparamagnetic iron oxide nanoparticles as potential MRI contrast agents. Nanoscale 2016, 8, 3278–3287.

Zhang, B. L.; Tu, Z. J.; Zhao, F. Y.; Wang, J. Superparamagnetic iron oxide nanoparticles prepared by using an improved polyol method. Appl. Surf. Sci. 2013, 266, 375–379.

Cui, H. T.; Liu, Y.; Ren, W. Z. Structure switch between α-Fe₂O₃, γ-Fe₂O₃ and Fe₃O₄ during the large scale and low temperature sol-gel synthesis of nearly monodispersed iron oxide nanoparticles. Adv. Powder Technol. 2013, 24, 93–97.

Lee, N.; Yoo, D.; Ling, D. S.; Cho, M. H.; Hyeon, T.; Cheon, J. Iron oxide based nanoparticles for multimodal imaging and magnetoresponsive therapy. Chem. Rev. 2015, 115, 10637–10689.

Jeon, M.; Halbert, M. V.; Stephen, Z. R.; Zhang, M. Q. Iron oxide nanoparticles as T₁ contrast agents for magnetic resonance imaging: Fundamentals, challenges, applications, and prospectives. Adv. Mater. 2021, 33, 1906539.

Zhou, Z. J.; Yang, L. J.; Gao, J. H.; Chen, X. Y. Structure-relaxivity relationships of magnetic nanoparticles for magnetic resonance imaging. Adv. Mater. 2019, 31, 1804567.

Tay, Z. W.; Savliwala, S.; Hensley, D. W.; Fung, K. L. B.; Colson, C.; Fellows, B. D.; Zhou, X. Y.; Huynh, Q.; Lu, Y.; Zheng, B. et al. Superferromagnetic nanoparticles enable order-of-magnitude resolution & sensitivity gain in magnetic particle imaging. Small Methods 2021, 5, 2100796.

Song, G. S.; Kenney, M.; Chen, Y. S.; Zheng, X. C.; Deng, Y.; Chen, Z.; Wang, S. X.; Gambhir, S. S.; Dai, H. J.; Rao, J. H. Carbon-coated FeCo nanoparticles as sensitive magnetic-particle-imaging tracers with photothermal and magnetothermal properties. Nat. Biomed. Eng. 2020, 4, 325–334.

Lak, A.; Disch, S.; Bender, P. Embracing defects and disorder in magnetic nanoparticles. Adv. Sci. 2021, 8, 2002682.

Stueber, D. D.; Villanova, J.; Aponte, I.; Xiao, Z.; Colvin, V. L. Magnetic nanoparticles in biology and medicine: Past, present, and future trends. Pharmaceutics 2021, 13, 943.

Huang, X.; Lin, C. Y.; Luo, C. C.; Guo, Y. H.; Li, J.; Wang, Y. P.; Xu, J. H.; Zhang, Y. W.; Wang, H.; Liu, Z. M. et al. Fe₃O₄@M nanoparticles for MRI-targeted detection in the early lesions of atherosclerosis. Nanomedicine 2021, 33, 102348.

Vaalma, S.; Rahmer, J.; Panagiotopoulos, N.; Duschka, R. L.; Borgert, J.; Barkhausen, J.; Vogt, F. M.; Haegele, J. Magnetic particle imaging (MPI): Experimental quantification of vascular stenosis using stationary stenosis phantoms. PLoS One 2017, 12, e0168902.

Yang, W.; Fei, J. W.; Xu, W.; Jiang, H. Y.; Sakran, M.; Hong, J. L.; Zhu, W. Y.; Zhou, X. M. A biosensor based on the biomimetic oxidase Fe₃O₄@MnO₂ for colorimetric determination of uric acid. Colloids Surf. B Biointerfaces 2022, 212, 112347.

Marques da Silva, M.; Wanderley Duarte Neto, J. M.; Barros Regueira, B. V.; Torres do Couto, M. T.; Vitória da Silva Sobral, R.; Sales Conniff, A. E.; Pedrosa Brandão Costa, R. M.; Cajubá de Britto Lira Nogueira, M.; Pereira da Silva Santos, N.; Pastrana, L. et al. Immobilization of fibrinolytic protease from Mucor subtilissimus UCP 1262 in magnetic nanoparticles. Protein Expr. Purif. 2022, 192, 106044.

Vazquez-Prada, K. X.; Moonshi, S. S.; Wu, Y.; Akther, F.; Tse, B. W. C.; Sokolowski, K. A.; Peter, K.; Wang, X.; Xu, G.; Ta, H. T. A Spiky Silver-Iron Oxide Nanoparticle for Highly Efficient Targeted Photothermal Therapy and Multimodal Imaging of Thrombosis. Small 2023, 19, e2205744.

Friedrich, R. P.; Cicha, I.; Alexiou, C. Iron oxide nanoparticles in regenerative medicine and tissue engineering. Nanomaterials 2021, 11, 2337.

Fuster, V.; Moreno, P. R.; Fayad, Z. A.; Corti, R.; Badimon, J. J. Atherothrombosis and high-risk plaque: Part I: Evolving concepts. J. Am. Coll. Cardiol. 2005, 46, 937–954.

Bakhshi, H.; Meyghani, Z.; Kishi, S.; Magalhães, T. A.; Vavere, A.; Kitslaar, P. H.; George, R. T.; Niinuma, H.; Reiber, J. H. C.; Betoko, A. et al. Comparative effectiveness of CT-derived atherosclerotic plaque metrics for predicting myocardial ischemia. JACC Cardiovasc. Imaging 2019, 12, 1367–1376.

Gulani, V.; Calamante, F.; Shellock, F. G.; Kanal, E.; Reeder, S. B. Gadolinium deposition in the brain: Summary of evidence and recommendations. Lancet Neurol. 2017, 16, 564–570.

Woollard, K. J.; Geissmann, F. Monocytes in atherosclerosis: Subsets and functions. Nat. Rev. Cardiol. 2010, 7, 77–86.

Kao, C. W.; Wu, P. T.; Liao, M. Y.; Chung, I. J.; Yang, K. C.; Tseng, W. Y. I.; Yu, J. Magnetic nanoparticles conjugated with peptides derived from monocyte chemoattractant protein-1 as a tool for targeting atherosclerosis. Pharmaceutics 2018, 10, 62.

Kim, M.; Sahu, A.; Kim, G. B.; Nam, G. H.; Um, W.; Shin, S. J.; Jeong, Y. Y.; Kim, I. S.; Kim, K.; Kwon, I. C. et al. Comparison of in vivo targeting ability between cRGD and collagen-targeting peptide conjugated nano-carriers for atherosclerosis. J Control. Release 2018, 269, 337–346.

Simberg, D.; Duza, T.; Park, J. H.; Essler, M.; Pilch, J.; Zhang, L. L.; Derfus, A. M.; Yang, M.; Hoffman, R. M.; Bhatia, S. et al. Biomimetic amplification of nanoparticle homing to tumors. Proc. Natl. Acad. Sci. USA 2007, 104, 932–936.

Poon, C.; Gallo, J.; Joo, J.; Chang, T.; Bañobre-López, M.; Chung, E. J. Hybrid, metal oxide-peptide amphiphile micelles for molecular magnetic resonance imaging of atherosclerosis. J. Nanobiotechnology 2018, 16, 92.

Ridker, P. M.; Rifai, N.; Stampfer, M. J.; Hennekens, C. H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000, 101, 1767–1772.

Mo, H. Q.; Fu, C. X.; Wu, Z. Y.; Liu, P.; Wen, Z. B.; Hong, Q. Q.; Cai, Y. B.; Li, G. X. IL-6-targeted ultrasmall superparamagnetic iron oxide nanoparticles for optimized MRI detection of atherosclerotic vulnerable plaques in rabbits. RSC Adv. 2020, 10, 15346–15353.

Ardissino, D.; Merlini, P. A.; Bauer, K. A.; Bramucci, E.; Ferrario, M.; Coppola, R.; Fetiveau, R.; Lucreziotti, S.; Rosenberg, R. D.; Mannucci, P. M. Thrombogenic potential of human coronary atherosclerotic plaques. Blood 2001, 98, 2726–2729.

Wei, Q. Z.; Wang, J.; Shi, W.; Zhang, B.; Jiang, H. W.; Du, M. Y.; Mei, H.; Hu, Y. Improved in vivo detection of atherosclerotic plaques with a tissue factor-targeting magnetic nanoprobe. Acta Biomater. 2019, 90, 324–336.

Tong, W.; Hui, H.; Shang, W. T.; Zhang, Y. Q.; Tian, F.; Ma, Q.; Yang, X.; Tian, J.; Chen, Y. D. Highly sensitive magnetic particle imaging of vulnerable atherosclerotic plaque with active myeloperoxidase-targeted nanoparticles. Theranostics 2021, 11, 506–521.

Kwon, H. J.; Shim, W. H.; Cho, G.; Cho, H. J.; Jung, H. S.; Lee, C. K.; Lee, Y. S.; Baek, J. H.; Kim, E. J.; Suh, J. Y. et al. Simultaneous evaluation of vascular morphology, blood volume and transvascular permeability using SPION-based, dual-contrast MRI: Imaging optimization and feasibility test. NMR Biomed. 2015, 28, 624–632.

Chen, C.; Ge, J. X.; Gao, Y.; Chen, L.; Cui, J. B.; Zeng, J. F.; Gao, M. Y. Ultrasmall superparamagnetic iron oxide nanoparticles: A next generation contrast agent for magnetic resonance imaging. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2022, 14, e1740.

Wang, J.; Jia, Y. H.; Wang, Q. Y.; Liang, Z. Y.; Han, G. X.; Wang, Z. J.; Lee, J.; Zhao, M.; Li, F. Y.; Bai, R. L. et al. An ultrahigh-field-tailored T₁-T₂ dual-mode MRI contrast agent for high-performance vascular imaging. Adv. Mater. 2021, 33, 2004917.

Franke, J.; Baxan, N.; Lehr, H.; Heinen, U.; Reinartz, S.; Schnorr, J.; Heidenreich, M.; Kiessling, F.; Schulz, V. Hybrid MPI-MRI system for dual-modal in situ cardiovascular assessments of real-time 3D blood flow quantification-a pre-clinical in vivo feasibility investigation. IEEE Trans. Med. Imaging 2020, 39, 4335–4345.

Mohtashamdolatshahi, A.; Kratz, H.; Kosch, O.; Hauptmann, R.; Stolzenburg, N.; Wiekhorst, F.; Sack, I.; Hamm, B.; Taupitz, M.; Schnorr, J. In vivo magnetic particle imaging: Angiography of inferior vena cava and aorta in rats using newly developed multicore particles. Sci. Rep. 2020, 10, 17247.

Herz, S.; Vogel, P.; Kampf, T.; Ruckert, M. A.; Veldhoen, S.; Behr, V. C.; Bley, T. A. Magnetic particle imaging for quantification of vascular stenoses: A phantom study. IEEE Trans. Med. Imaging 2018, 37, 61–67.

Xia, R.; Zhu, T.; Zhang, Y.; He, B.; Wang, L.; Zheng, J.; Gao, F. B. Microcirculation of intramyocardial hemorrhage caused by reperfused myocardial infarctions with ultrasmall superparamagnetic iron oxide cardiac magnetic resonance imaging. Acta Radiol. 2022, 63, 1469–1474.

Members, W. C.; Gulati, M.; Levy, P. D.; Mukherjee, D.; Amsterdam, E.; Bhatt, D. L.; Birtcher, K. K.; Blankstein, R.; Boyd, J.; Bullock-Palmer, R. P. et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain:A report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. J. Am. Coll. Cardiol. 2021, 78, e187–e285.

Fathil, M. F. M.; Md Arshad, M. K.; Gopinath, S. C. B.; Hashim, U.; Adzhri, R.; Ayub, R. M.; Ruslinda, A. R.; Nuzaihan M N, M.; Azman, A. H.; Zaki, M. et al. Diagnostics on acute myocardial infarction: Cardiac troponin biomarkers. Biosens. Bioelectron. 2015, 70, 209–220.

Qureshi, A.; Gurbuz, Y.; Niazi, J. H. Biosensors for cardiac biomarkers detection: A review. Sens. Actuators B Chem. 2012, 171–172, 62–76.

Mohammed, M. I.; Desmulliez, M. P. Y. Lab-on-a-chip based immunosensor principles and technologies for the detection of cardiac biomarkers: A review. Lab Chip 2011, 11, 569–595.

Sun, D. P.; Lin, X. G.; Lu, J.; Wei, P.; Luo, Z. B.; Lu, X. G.; Chen, Z. G.; Zhang, L. Y. DNA nanotetrahedron-assisted electrochemical aptasensor for cardiac troponin I detection based on the co-catalysis of hybrid nanozyme, natural enzyme and artificial DNAzyme. Biosens. Bioelectron. 2019, 142, 111578.

Lin, C. B.; Li, L. J.; Feng, J.; Zhang, Y.; Guo, H. Y. X.; Lin, X.; Li, R. A novel Apt-SERS platform for the determination of cardiac troponin I based on coral-like silver-modified magnetic substrate and BCA method. Anal. Chim. Acta 2022, 1225, 340253.

Orlov, A. V.; Malkerov, J. A.; Novichikhin, D. O.; Znoyko, S. L.; Nikitin, P. I. Multiplex label-free kinetic characterization of antibodies for rapid sensitive cardiac troponin i detection based on functionalized magnetic nanotags. Int. J. Mol. Sci. 2022, 23, 4474.

Li, X. Q.; Cai, L. J.; Wang, Y.; Hong, J.; Zhang, D. G. Hydrogel encapsulated core-shell photonic barcodes for multiplex biomarker quantification. Anal. Chem. 2023, 95, 3806–3810.

Koupenova, M.; Clancy, L.; Corkrey, H. A.; Freedman, J. E. Circulating platelets as mediators of immunity, inflammation, and thrombosis. Circ. Res. 2018, 122, 337–351.

Rink, T. J.; Sage, S. O. Calcium signaling in human platelets. Annu. Rev. Physiol. 1990, 52, 431–449.

Sage, S. O.; Pugh, N.; Farndale, R. W.; Harper, A. G. S. Pericellular Ca²⁺ recycling potentiates thrombin-evoked Ca²⁺ signals in human platelets. Physiol. Rep. 2013, 1, e00085.

Cabrera, D.; Walker, K.; Moise, S.; Telling, N. D.; Harper, A. G. S. Controlling human platelet activation with calcium-binding nanoparticles. Nano Res. 2020, 13, 2697–2705.

Zhong, Y. X.; Zhang, Y.; Xu, J.; Zhou, J.; Liu, J.; Ye, M.; Zhang, L.; Qiao, B.; Wang, Z. G.; Ran, H. T. et al. Low-intensity focused ultrasound-responsive phase-transitional nanoparticles for thrombolysis without vascular damage: A synergistic nonpharmaceutical strategy. ACS Nano 2019, 13, 3387–3403.

Haegele, J.; Biederer, S.; Wojtczyk, H.; Gräser, M.; Knopp, T.; Buzug, T. M.; Barkhausen, J.; Vogt, F. M. Toward cardiovascular interventions guided by magnetic particle imaging: First instrument characterization. Magn. Reson. Med. 2013, 69, 1761–1767.

Haegele, J.; Rahmer, J.; Gleich, B.; Borgert, J.; Wojtczyk, H.; Panagiotopoulos, N.; Buzug, T. M.; Barkhausen, J.; Vogt, F. M. Magnetic particle imaging: Visualization of instruments for cardiovascular intervention. Radiology 2012, 265, 933–938.

Haegele, J.; Vaalma, S.; Panagiotopoulos, N.; Barkhausen, J.; Vogt, F. M.; Borgert, J.; Rahmer, J. Multi-color magnetic particle imaging for cardiovascular interventions. Phys. Med. Biol. 2016, 61, N415–N426.

Lotz, J. Interventional vascular MRI: Moving forward. Eur. Heart J. 2013, 34, 327–329.

Blanco, E.; Segura-Ibarra, V.; Bawa, D.; Nafiujjaman, M.; Wu, S. H.; Liu, H. R.; Ferrari, M.; Lumsden, A. B.; Shah, D. J.; Lin, C. H. Functionalization of endovascular devices with superparamagnetic iron oxide nanoparticles for interventional cardiovascular magnetic resonance imaging. Biomed. Microdevices 2019, 21, 38.

Giustino, G.; Colombo, A.; Camaj, A.; Yasumura, K.; Mehran, R.; Stone, G. W.; Kini, A.; Sharma, S. K. Coronary in-stent restenosis: JACC state-of-the-art review. J. Am. Coll. Cardiol. 2022, 80, 348–372.

Shlofmitz, E.; Iantorno, M.; Waksman, R. Restenosis of drug-eluting stents: A new classification system based on disease mechanism to guide treatment and state-of-the-art review. Circ. Cardiovasc. Interv. 2019, 12, e007023.

Pislaru, S. V.; Harbuzariu, A.; Gulati, R.; Witt, T.; Sandhu, N. P.; Simari, R. D.; Sandhu, G. S. Magnetically targeted endothelial cell localization in stented vessels. J. Am. Coll. Cardiol. 2006, 48, 1839–1845.

Lee, J. S.; Han, P.; Song, E.; Kim, D.; Lee, H.; Labowsky, M.; Taavitsainen, J.; Ylä-Herttuala, S.; Hytönen, J.; Gülcher, M. et al. Magnetically coated bioabsorbable stents for renormalization of arterial vessel walls after stent implantation. Nano Lett. 2018, 18, 272–281.

Tefft, B. J.; Uthamaraj, S.; Harbuzariu, A.; Harburn, J. J.; Witt, T. A.; Newman, B.; Psaltis, P. J.; Hlinomaz, O.; Holmes, D. R. Jr.; Gulati, R. et al. Nanoparticle-mediated cell capture enables rapid endothelialization of a novel bare metal stent. Tissue Eng. Part A 2018, 24, 1157–1166.

Akhmedov, S.; Afanasyev, S.; Trusova, M.; Postnikov, P.; Rogovskaya, Y.; Grakova, E.; Kopeva, K.; Carreon Paz, R. K.; Balakin, S.; Wiesmann, H. P. et al. Chemically modified biomimetic carbon-coated iron nanoparticles for stent coatings: In vitro cytocompatibility and in vivo structural changes in human atherosclerotic plaques. Biomedicines 2021, 9, 802.

Hataminia, F.; Majidi, R. F.; Najafi Tireh Shabankareh, A.; Ghanbari, H. Green synthesis of oxidized starch with a novel catalyst based on Fe₃O₄ nanoparticles and H₂O₂ reagent to form thermoplastic as a stable gel coating on the cardiovascular stents. Int. J. Biol. Macromol. 2022, 219, 290–303.

Piccolo, R.; Bonaa, K. H.; Efthimiou, O.; Varenne, O.; Baldo, A.; Urban, P.; Kaiser, C.; Remkes, W.; Räber, L.; de Belder, A. et al. Drug-eluting or bare-metal stents for percutaneous coronary intervention: A systematic review and individual patient data meta-analysis of randomised clinical trials. Lancet 2019, 393, 2503–2510.

Li, M. X.; Deng, D. W.; Chen, Z.; Liu, W. T.; Zhao, G. T.; Zhang, Y.; Yang, F.; Ni, Z. H. Magnetic nanoparticle loaded biodegradable vascular stents for magnetic resonance imaging and long-term visualization. J. Mater. Chem. B 2023, 11, 3669–3678.

Fontana, A. R.; Camargo, A.; Martinez, L. D.; Altamirano, J. C. Dispersive solid-phase extraction as a simplified clean-up technique for biological sample extracts. Determination of polybrominated diphenyl ethers by gas chromatography-tandem mass spectrometry. J. Chromatogr. A 2011, 1218, 2490–2496.

Farajzadeh, M. A.; Yadeghari, A.; Abbaspour, M. Dispersive solid phase extraction using magnetic nanoparticles performed in a narrow-bored tube for extraction of atorvastatin, losartan, and valsartan in plasma. Adv. Pharm. Bull. 2019, 9, 138–146.

ALOthman, Z. A.; Alsheetan, K. M.; Aboul-Enein, H. Y.; Ali, I. Applications of shun shell column and nanocomposite sorbent for analysis of eleven anti-hypertensive in human plasma. J. Chromatogr. B 2020, 1146, 122125.

Yu, Y. M.; Ma, B. Y.; Jiang, X. B.; Guo, C.; Liu, Z.; Li, N.; Chai, Y. M.; Wang, L. C.; Du, Y. Z.; Wang, B. et al. Amphiphilic shell nanomagnetic adsorbents for selective and highly efficient capture of low-density lipoprotein from hyperlipidaemia serum. J. Mater. Chem. B 2022, 10, 4856–4866.

Patra, J. K.; Das, G.; Fraceto, L. F.; Campos, E. V. R.; Rodriguez-Torres, M. D. P.; Acosta-Torres, L. S.; Diaz-Torres, L. A.; Grillo, R.; Swamy, M. K.; Sharma, S. et al. Nano based drug delivery systems: Recent developments and future prospects. J. Nanobiotechnology 2018, 16, 71.

Puglisi, A.; Bassini, S.; Reimhult, E. Cyclodextrin-appended superparamagnetic iron oxide nanoparticles as cholesterol-mopping agents. Front. Chem. 2021, 9, 795598.

Nazari, H.; Heirani-Tabasi, A.; Hajiabbas, M.; Salimi Bani, M.; Nazari, M.; Pirhajati Mahabadi, V.; Rad, I.; Kehtari, M.; Ahmadi Tafti, S. H.; Soleimani, M. Incorporation of SPION-casein core-shells into silk-fibroin nanofibers for cardiac tissue engineering. J. Cell. Biochem. 2020, 121, 2981–2993.

Zwi-Dantsis, L.; Wang, B.; Marijon, C.; Zonetti, S.; Ferrini, A.; Massi, L.; Stuckey, D. J.; Terracciano, C. M.; Stevens, M. M. Remote magnetic nanoparticle manipulation enables the dynamic patterning of cardiac tissues. Adv. Mater. 2020, 32, 1904598.

Mou, Y. C.; Lv, S. H.; Xiong, F.; Han, Y.; Zhao, Y. W.; Li, J. J.; Gu, N.; Zhou, J. Effects of different doses of 2, 3-dimercaptosuccinic acid-modified Fe₂O₃ nanoparticles on intercalated discs in engineered cardiac tissues. J. Biomed. Mater. Res. B Appl. Biomater. 2018, 106, 121–130.

Burnham, M. P.; Harvey, R.; Sargeant, R.; Fertig, N.; Haddrick, M. A scalable approach reveals functional responses of iPSC cardiomyocyte 3D spheroids. SLAS Discov. 2021, 26, 352–363.

Rama, E.; Mohapatra, S. R.; Melcher, C.; Nolte, T.; Dadfar, S. M.; Brueck, R.; Pathak, V.; Rix, A.; Gries, T.; Schulz, V. et al. Monitoring the remodeling of biohybrid tissue-engineered vascular grafts by multimodal molecular imaging. Adv. Sci. 2022, 9, 2105783.

Al-Ansari, D. E.; Mohamed, N. A.; Marei, I.; Zekri, A.; Kameno, Y.; Davies, R. P.; Lickiss, P. D.; Rahman, M. M.; Abou-Saleh, H. Internalization of metal-organic framework nanoparticles in human vascular cells: Implications for cardiovascular disease therapy. Nanomaterials 2020, 10, 1028.

Liu, Y. Y.; Shi, M. R.; Xu, M. M.; Yang, H.; Wu, C. H. Multifunctional nanoparticles of Fe₃O₄@SiO₂(FITC)/PAH conjugated the recombinant plasmid of pIRSE2-EGFP/VEGF₁₆₅ with dual functions for gene delivery and cellular imaging. Expert Opin. Drug Deliv. 2012, 9, 1197–1207.

Mannell, H.; Pircher, J.; Räthel, T.; Schilberg, K.; Zimmermann, K.; Pfeifer, A.; Mykhaylyk, O.; Gleich, B.; Pohl, U.; Krötz, F. Targeted endothelial gene delivery by ultrasonic destruction of magnetic microbubbles carrying lentiviral vectors. Pharm. Res. 2012, 29, 1282–1294.

Zhang, L.; Tian, X. Y.; Chan, C. K. W.; Bai, Q. Q.; Cheng, C. K.; Chen, F. M.; Cheung, M. S. H.; Yin, B. H.; Yang, H. R.; Yung, W. Y. et al. Promoting the delivery of nanoparticles to atherosclerotic plaques by DNA coating. ACS Appl. Mater. Interfaces 2019, 11, 13888–13904.

Zhang, W.; Veisi, H.; Sharifi, R.; Salamat, D.; Karmakar, B.; Hekmati, M.; Hemmati, S.; Zangeneh, M. M.; Zhang, Z. Y.; Su, Q. Fabrication of Pd NPs on pectin-modified Fe₃O₄ NPs: A magnetically retrievable nanocatalyst for efficient C-C and C-N cross coupling reactions and an investigation of its cardiovascular protective effects. Int. J. Biol. Macromol. 2020, 160, 1252–1262.

Hewlin, R. L. Jr.; Tindall, J. M. Computational assessment of magnetic nanoparticle targeting efficiency in a simplified circle of willis arterial model. Int. J. Mol. Sci. 2023, 24, 2545.

Hewlin, R. L. Jr.; Ciero, A.; Kizito, J. P. Development of a two-way coupled eulerian-lagrangian computational magnetic nanoparticle targeting model for pulsatile flow in a patient-specific diseased left carotid bifurcation artery. Cardiovasc Eng. Technol. 2019, 10, 299–313.

Zhang, S. H.; Xu, W.; Gao, P.; Chen, W. L.; Zhou, Q. Construction of dual nanomedicines for the imaging and alleviation of atherosclerosis. Artif. Cells Nanomed. Biotechnol. 2020, 48, 169–179.

Bonnet, S.; Prévot, G.; Mornet, S.; Jacobin-Valat, M. J.; Mousli, Y.; Hemadou, A.; Duttine, M.; Trotier, A.; Sanchez, S.; Duonor-Cérutti, M. et al. A nano-emulsion platform functionalized with a fully human scFv-Fc antibody for atheroma targeting: Towards a theranostic approach to atherosclerosis. Int. J. Mol. Sci. 2021, 22, 5188.

Gao, B. Y.; Xu, J. S.; Zhou, J.; Zhang, H.; Yang, R.; Wang, H.; Huang, J. B.; Yan, F.; Luo, Y. Multifunctional pathology-mapping theranostic nanoplatforms for US/MR imaging and ultrasound therapy of atherosclerosis. Nanoscale 2021, 13, 8623–8638.

Banik, B.; Surnar, B.; Askins, B. W.; Banerjee, M.; Dhar, S. Dual-targeted synthetic nanoparticles for cardiovascular diseases. ACS Appl. Mater. Interfaces 2020, 12, 6852–6862.

Qiu, P. D.; Xu, Y. H. The construction of multifunctional nanoparticles system for dual-modal imaging and arteriosclerosis targeted therapy. Am. J. Transl. Res. 2021, 13, 4026–4039.

Hou, J. X.; Zhou, J.; Chang, M. Q.; Bao, G. C.; Xu, J.; Ye, M.; Zhong, Y. X.; Liu, S. L.; Wang, J. R.; Zhang, W. et al. LIFU-responsive nanomedicine enables acoustic droplet vaporization-induced apoptosis of macrophages for stabilizing vulnerable atherosclerotic plaques. Bioact. Mater 2022, 16, 120–133.

Mu, D.; Wang, W. S.; Li, J. H.; Lv, P.; Liu, R. Y.; Tan, Y.; Zhong, C. X.; Qi, Y.; Sun, X.; Liu, Y. H. et al. Ultrasmall Fe(III)-tannic acid nanoparticles to prevent progression of atherosclerotic plaques. ACS Appl. Mater. Interfaces 2021, 13, 33915–33925.

Mu, D.; Wang, X.; Wang, H. T.; Sun, X.; Dai, Q.; Lv, P.; Liu, R. Y.; Qi, Y.; Xie, J.; Xu, B. et al. Chemiexcited photodynamic therapy integrated in polymeric nanoparticles capable of mri against atherosclerosis. Int. J. Nanomedicine 2022, 17, 2353–2366.

Wendelboe, A. M.; Raskob, G. E. Global burden of thrombosis: Epidemiologic aspects. Circ. Res. 2016, 118, 1340–1347.

Capilupi, M. J.; Kerath, S. M.; Becker, L. B. Vagus nerve stimulation and the cardiovascular system. Cold Spring Harb. Perspect. Med. 2020, 10, a034173.

Sun, X.; Wei, Z. L.; Li, Y. Y.; Wang, J. Z.; Hu, J. X.; Yin, Y.; Xie, J.; Xu, B. Renal denervation restrains the inflammatory response in myocardial ischemia-reperfusion injury. Basic Res. Cardiol. 2020, 115, 15.

Wang, K.; Qi, Y.; Gu, R.; Dai, Q.; Shan, A. Q.; Li, Z.; Gong, C. Y.; Chang, L.; Hao, H.; Duan, J. F. et al. Renal denervation attenuates adverse remodeling and intramyocardial inflammation in acute myocardial infarction with ischemia-reperfusion injury. Front. Cardiovasc. Med. 2022, 9, 832014.

Bao, S. Y.; Lu, Y.; Zhang, J.; Xue, L.; Zhang, Y. W.; Wang, P.; Zhang, F. X.; Gu, N.; Sun, J. F. Rapid improvement of heart repair in rats after myocardial infarction by precise magnetic stimulation on the vagus nerve with an injectable magnetic hydrogel. Nanoscale 2023, 15, 3532–3541.

Sosnovik, D. E.; Nahrendorf, M.; Weissleder, R. Magnetic nanoparticles for MR imaging: Agents, techniques and cardiovascular applications. Basic Res. Cardiol. 2008, 103, 122–130.

Chen, J. L.; Yang, J.; Liu, R. Y.; Qiao, C. M.; Lu, Z. G.; Shi, Y. J.; Fan, Z. M.; Zhang, Z. Z.; Zhang, X. Dual-targeting theranostic system with mimicking apoptosis to promote myocardial infarction repair via modulation of macrophages. Theranostics 2017, 7, 4149–4167.

Li, M. X.; Li, J.; Chen, J. P.; Liu, Y.; Cheng, X.; Yang, F.; Gu, N. Platelet membrane biomimetic magnetic nanocarriers for targeted delivery and in situ generation of nitric oxide in early ischemic stroke. ACS Nano 2020, 14, 2024–2035.

Zhao, J. X.; Li, X. L.; Hu, J. X.; Chen, F.; Qiao, S. H.; Sun, X.; Gao, L.; Xie, J.; Xu, B. Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization. Cardiovasc. Res. 2019, 115, 1205–1216.

Wei, Z. L.; Chen, Z. Y.; Zhao, Y. C.; Fan, F.; Xiong, W. D.; Song, S.; Yin, Y.; Hu, J. J.; Yang, K.; Yang, L. B. et al. Mononuclear phagocyte system blockade using extracellular vesicles modified with CD47 on membrane surface for myocardial infarction reperfusion injury treatment. Biomaterials 2021, 275, 121000.

Wang, J. Z.; Chen, Z. W.; Dai, Q.; Zhao, J. X.; Wei, Z. L.; Hu, J. X.; Sun, X.; Xie, J.; Xu, B. Intravenously delivered mesenchymal stem cells prevent microvascular obstruction formation after myocardial ischemia/reperfusion injury. Basic Res. Cardiol. 2020, 115, 40.

Gong, C. Y.; Chang, L.; Sun, X.; Qi, Y.; Huang, R.; Chen, K.; Wang, B.; Kang, L.; Wang, L. N.; Xu, B. Infusion of two-dose mesenchymal stem cells is more effective than a single dose in a dilated cardiomyopathy rat model by upregulating indoleamine 2, 3-dioxygenase expression. Stem Cell Res. Ther. 2022, 13, 409.

Amir, G.; Ma, X. Y.; Reddy, V. M.; Hanley, F. L.; Reinhartz, O.; Ramamoorthy, C.; Riemer, R. K. Dynamics of human myocardial progenitor cell populations in the neonatal period. Ann. Thorac. Surg. 2008, 86, 1311–1319.

Goodfellow, F. T.; Simchick, G. A.; Mortensen, L. J.; Stice, S. L.; Zhao, Q. Tracking and quantification of magnetically labeled stem cells using magnetic resonance imaging. Adv. Funct. Mater. 2016, 26, 3899–3915.

Santoso, M. R.; Yang, P. C. Magnetic nanoparticles for targeting and imaging of stem cells in myocardial infarction. Stem Cells Int. 2016, 2016, 4198790.

Sun, R.; Wang, X. D.; Nie, Y.; Hu, A.; Liu, H. R.; Zhang, K.; Zhang, L.; Wu, Q. H.; Li, K.; Liu, C. C. et al. Targeted trapping of endogenous endothelial progenitor cells for myocardial ischemic injury repair through neutrophil-mediated SPIO nanoparticle-conjugated CD34 antibody delivery and imaging. Acta Biomater. 2022, 146, 421–433.

Liu, H. R.; Sun, R.; Wang, L.; Chen, X. Y.; Li, G. L.; Cheng, Y.; Zhai, G. H.; Bay, B. H.; Yang, F.; Gu, N. et al. Biocompatible iron oxide nanoring-labeled mesenchymal stem cells: An innovative magnetothermal approach for cell tracking and targeted stroke therapy. ACS Nano 2022, 16, 18806–18821.

Wang, H. Y.; Ge, Y. Q.; Sun, J. F.; Wang, H.; Gu, N. Magnetic sensor based on image processing for dynamically tracking magnetic moment of single magnetic mesenchymal stem cell. Biosens. Bioelectron. 2020, 169, 112593.

Yan, S.; Hu, K.; Zhang, M.; Sheng, J. Y.; Xu, X. Q.; Tang, S. J.; Li, Y.; Yang, S.; Si, G. X.; Mao, Y. et al. Extracellular magnetic labeling of biomimetic hydrogel-induced human mesenchymal stem cell spheroids with ferumoxytol for MRI tracking. Bioact. Mater. 2023, 19, 418–428.

Segers, F. M. E.; Ruder, A. V.; Westra, M. M.; Lammers, T.; Dadfar, S. M.; Roemhild, K.; Lam, T. S.; Kooi, M. E.; Cleutjens, K. B. J. M.; Verheyen, F. K. et al. Magnetic resonance imaging contrast-enhancement with superparamagnetic iron oxide nanoparticles amplifies macrophage foam cell apoptosis in human and murine atherosclerosis. Cardiovasc. Res. 2023, 118, 3346–3359.

Chen, B.; Sun, J. F.; Fan, F. G.; Zhang, X. Z.; Qin, Z. G.; Wang, P.; Li, Y.; Zhang, X. Q.; Liu, F.; Liu, Y. L. et al. Ferumoxytol of ultrahigh magnetization produced by hydrocooling and magnetically internal heating co-precipitation. Nanoscale 2018, 10, 7369–7376.

Hedgire, S.; Krebill, C.; Wojtkiewicz, G. R.; Oliveira, I.; Ghoshhajra, B. B.; Hoffmann, U.; Harisinghani, M. G. Ultrasmall superparamagnetic iron oxide nanoparticle uptake as noninvasive marker of aortic wall inflammation on MRI: Proof of concept study. Br. J. Radiol. 2018, 91, 20180461.

Shahrouki, P.; Khan, S. N.; Yoshida, T.; Iskander, P. J.; Ghahremani, S.; Finn, J. P. High-resolution three-dimensional contrast-enhanced magnetic resonance venography in children: Comparison of gadofosveset trisodium with ferumoxytol. Pediatr. Radiol. 2022, 52, 501–512.

Roy, C. W.; Di Sopra, L.; Whitehead, K. K.; Piccini, D.; Yerly, J.; Heerfordt, J.; Ghosh, R. M.; Fogel, M. A.; Stuber, M. Free-running cardiac and respiratory motion-resolved 5D whole-heart coronary cardiovascular magnetic resonance angiography in pediatric cardiac patients using ferumoxytol. J. Cardiovasc. Magn. Reson. 2022, 24, 39.

Yoshida, T.; Nguyen, K. L.; Shahrouki, P.; Quinones-Baldrich, W. J.; Lawrence, P. F.; Finn, J. P. Intermodality feature fusion combining unenhanced computed tomography and ferumoxytol-enhanced magnetic resonance angiography for patient-specific vascular mapping in renal impairment. J. Vasc. Surg. 2020, 71, 1674–1684.

Usman, A.; Patterson, A. J.; Yuan, J. M.; Cluroe, A.; Patterson, I.; Graves, M. J.; Gillard, J. H.; Sadat, U. Ferumoxytol-enhanced three-dimensional magnetic resonance imaging of carotid atheroma- a feasibility and temporal dependence study. Sci. Rep. 2020, 10, 1808.

Stirrat, C. G.; Alam, S.; MacGillivray, T. J.; Gray, C.; Dweck, M. R.; Jones, V.; Wallace, W.; Payne, J. R.; Prasad, S. K.; Gardner, R. S. et al. Ferumoxytol-enhanced MRI in patients with prior cardiac transplantation. Open Heart 2019, 6, e001115.

Stirrat, C. G.; Alam, S. R.; MacGillivray, T. J.; Gray, C. D.; Dweck, M. R.; Dibb, K.; Spath, N.; Payne, J. R.; Prasad, S. K.; Gardner, R. S. et al. Ferumoxytol-enhanced magnetic resonance imaging in acute myocarditis. Heart 2018, 104, 300–305.

Nguyen, K. L.; Moriarty, J. M.; Plotnik, A. N.; Aksoy, O.; Yoshida, T.; Shemin, R. J.; Suh, W. M.; Finn, J. P. Ferumoxytol-enhanced MR angiography for vascular access mapping before transcatheter aortic valve replacement in patients with renal impairment: A step toward patient-specific care. Radiology 2018, 286, 326–337.

Dong, Z.; Si, G. X.; Zhu, X. M.; Li, C.; Hua, R.; Teng, J. Z.; Zhang, W. H.; Xu, L. L.; Qian, W.; Liu, B. et al. Diagnostic performance and safety of a novel ferumoxytol-enhanced coronary magnetic resonance angiography. Circ. Cardiovasc. Imaging 2023, 16, 580–590.

Lagan, J.; Naish, J. H.; Simpson, K.; Zi, M.; Cartwright, E. J.; Foden, P.; Morris, J.; Clark, D.; Birchall, L.; Caldwell, J. et al. Substrate for the myocardial inflammation-heart failure hypothesis identified using novel USPIO methodology. JACC Cardiovasc. Imaging 2021, 14, 365–376.

Zheng, K. H.; Schoormans, J.; Stiekema, L. C. A.; Calcagno, C.; Cicha, I.; Alexiou, C.; Strijkers, G. J.; Nederveen, A. J.; Stroes, E. S. G.; Coolen, B. F. Plaque permeability assessed with DCE-MRI associates with USPIO uptake in patients with peripheral artery disease. JACC Cardiovasc. Imaging 2019, 12, 2081–2083.

Zheng, X. W.; Chen, Y. J.; Wang, Z. M.; Song, L. N.; Zhang, Y.; Gu, N.; Xiong, F. Preparation and in vitro cellular uptake assessment of multifunctional rubik-like magnetic nano-assemblies. J. Nanosci. Nanotechnol. 2019, 19, 3301–3309.